PharmaCyte Biotech (PMCB) Cash & Equivalents (2012 - 2026)
PharmaCyte Biotech (PMCB) posted Cash & Equivalents of $17.74 million for fiscal Q1 2027 (quarter ended Jul 31, 2026), up 34.6% from $13.18 million a year earlier but down 4.6% from the prior quarter.
Powered by 
Analysis
PharmaCyte Biotech (PMCB) Cash & Equivalents (2012 - 2026) Analysis & Trends
At the end of FY2026 (ended Apr 30, 2026), PharmaCyte Biotech's Cash & Equivalents came in at $18.6 million, up 22.6% from FY2025.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of 53.2% (FY2021 to FY2026).
- In prior fiscal years, PharmaCyte Biotech's Cash & Equivalents was $15.17 million in FY2025 (-69.8%), $50.18 million in FY2024 (-26.2%), $68.04 million in FY2023 (-20.3%) and $85.4 million in FY2022.
- Quarterly Cash & Equivalents has run from a low of $13.18 million in fiscal Q1 2026 to a high of $86.94 million in fiscal Q2 2022 over five years.
- On a year-over-year basis, Cash & Equivalents has increased in each of the last three quarters, with an average decline of 27.5% over the last eight quarters.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was fiscal Q1 2027, with growth of 34.6%; the weakest was fiscal Q3 2025, with a decline of 73.2%.
- According to Business Quant data, Cash & Equivalents for the three prior fiscal quarters was $18.6 million (Q4 2026), $20.17 million (Q3 2026) and $15.41 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 976.00 Mn |
| 10 | PharmaCyte Biotech | 3.79 Mn | -69.05 Mn | - | 17.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 17.74 Mn |
| Apr 30, 2026 | 18.60 Mn |
| Jan 31, 2026 | 20.17 Mn |
| Oct 31, 2025 | 15.41 Mn |
| Jul 31, 2025 | 13.18 Mn |
| Apr 30, 2025 | 15.17 Mn |
| Jan 31, 2025 | 16.38 Mn |
| Oct 31, 2024 | 20.84 Mn |
| Jul 31, 2024 | 32.64 Mn |
| Apr 30, 2024 | 50.18 Mn |
| Jan 31, 2024 | 61.21 Mn |
| Oct 31, 2023 | 73.43 Mn |
| Jul 31, 2023 | 74.66 Mn |
| Apr 30, 2023 | 68.04 Mn |
| Jan 31, 2023 | 72.64 Mn |
| Oct 31, 2022 | 76.96 Mn |
| Jul 31, 2022 | 82.23 Mn |
| Apr 30, 2022 | 85.40 Mn |
| Jan 31, 2022 | 86.64 Mn |
| Oct 31, 2021 | 86.94 Mn |
API Access
PharmaCyte Biotech Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PMCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "PMCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PMCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();